HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

CANCER RESEARCH(2022)

引用 8|浏览15
暂无评分
摘要
Cancer Research UK (CRUK/07/015).
更多
查看译文
关键词
Breast cancer,HER2+,Aromatase inhibitors,HER2-Enriched subtype
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要